RevCycleAI Brief
Published researchClinical intelligence and utilization management platform for health plans and risk-bearing providers, using AI and agentic workflows to streamline prior authorization and adjacent payer-provider decisions.
✦ Ask RevCycleAI about Cohere Health
Pro AI analystGo deeper on competitors, positioning, buyers, funding and market signals.
Unlock Ask RevCycleAI →Key findings
Research highlightsCohere's expansion into payment accuracy and risk adjustment puts it closer to a payer operating platform than a prior-auth point solution. That increases TAM but also broadens its competitive set and implementation complexity.
Raised $90M Series C led by Temasek, bringing total funding to $200M
Announced expansion beyond prior authorization into risk adjustment, population health management and payment accuracy
RevCycleAI Intelligence Scores
MethodologyMarket Matrix: Emerging · Impact 48 · Capability 51
Funding & transaction history
2 trackedAI-driven prior authorization and clinical intelligence platform for health plans and risk-bearing providers. Automates PA determinations using clinical evidence at scale.
Growth equity raise to meet increased demand following CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). Preceded the $90M Series C.